Trial Profile
If thrombelastography reaction time (TEG R) could detect the anticoagulant effect of dabigatran showing a correlation between TEG R, Hemoclot Thrombin Inhibitor (HTI) assay and Ecarin Clotting Time (ECT) in patients with non-valvular atrial fibrillation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Sep 2018
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary)
- Indications Thrombosis
- Focus Therapeutic Use
- 20 Sep 2018 New trial record